Implantable dual-chamber cardioverter-defibrillator-pacemaker

Current Cardiology Reports

Volumn 2, Issue 4, 2000, Pages 335-340

  Pfeiffer, Dietrich ^a   Mende, Maika ^a   Hagendorff, Andreas ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEFIBRILLATOR; EQUIPMENT DESIGN; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; METHODOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 0034223135     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-000-0090-6     Document Type: Review

References (62)

1. The Antiarrhythmic versus Implantable Defibrillators (AVID) Investigators: A comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997, 337:1576-1583.
2. Connolly SJ, Gent M, Roberts DS, et al. : Canadian implantable defibrillator study (CIDS): Study design and organization. Am J Cardiol 1993, 72:103F-108F.
3. Siebels J, Kuck KH: Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the cardiac arrest study Hamburg). Am J Cardiol 1994, 127:1139-1144.
4. Moss AJ, Hall WJ, Cannom DS, ET AL. : Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New Engl J Med 1996, 335:1993-1940.
5. Sheahan R, Dorian P, Poludnikiewicz M, Newman D: Dual device therapy in the setting of changing ICD technology: Device-device interaction revisited. PACE 1997, 20:1704-1707.
6. Blanck Z, Niazi I, Axtell K, et al. : Feasibility of concomitant implantation of permanent transvenous pacemaker and defibrillator systems. Am J Cardiol 1994, 74:1249-1253.
7. Brooks R, Garan H, McGovern BA, Ruskin JN: Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers. Am Heart J 1995, 129:45-53.
8. Calkins H, Brinker J, Veltri E, et al. : Clinical interactions between pacemakers and automatic implantable cardioverter-defibrillators. J Am Coll Cardiol 1990, 16:666-673.
9. Geiger MJ, ONeill P, Sharma A, et al. : Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemaker. PACE 1997, 20:624-630.
10. Deshmukh P, Anderson K: Myopotential sensing by a dual chamber implantable cardioverter defibrillator: two case reports. J Cardiovasc Electrophysiol 1998, 9:767-772.
11. Pinski SL, Fahy GJ: The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995, 92:1651-1664.
12. Higgins SL: Impact of the multicenter automatic implantation trial on implantable cardioverter defibrillator indication trends. Am J Cardiol 1999, 83:79D-82D.
13. Higgins SL, Williams SK, Pak JP, Meyer DB: Indications for implantation of a dual-chamber pacemaker combined with an implantable cardioverter- defibrillator. Am J Cardiol 1998, 81:1360-1362.
14. Geelen P, Lorga A, Chauvin M, et al. : The value of DDD pacing in patients with an implantable cardioverter defibrillator. PACE 1997, 20:177-181.
15. Best PJM, Hayes DL, Stanton MS: The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillator. PACE 1999, 22:79-85.
16. Gregoratos G, Cheitlin MD, Conill A, et al. : ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary. Circulation 1998, 97:1325-1335.
17. Santini M, Ansalone G, Auriti A, et al. : Indications for dualchamber (DDD) pacing in implantable cardioverter-defibrillator patients. Am J Cardiol 1996, 78(suppl 5A):116-118.
18. Capucci A, Villani GQ, Groppi F, et al. : Comparison of therapy detection times between implantable cardioverter defibrillators with standard dual-and single-chamber pacing. J Interv Card Electrophysiol 1999, 3:329-333.
19. Trappe HJ, Achtelik M, Pfitzner P, et al. : Single-chamber versus dual-chamber implantable cardioverter defibrillators: indications and clinical results. Am J Cardiol 1999, 83:8D-16D.
20. Linde C, Gadler F, Edner M, et al. : Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995, 75:919-923.
21. Kelly PA, Mann DE, Reiter MJ: Atrial fibrillation after implantable cardioverter defibrillator implantation. PACE 1995, 18:379-385.
22. Schmitt C, Montero M, Melichercik J: Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. PACE 1994, 17:295-302.
23. Swerdlow CD, Chen P-S, Kass RM, et al. : Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994, 23:1342-1355.
24. Wood MA, Bruce SS, Damiano RJ, et al. : Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. J Am Coll Cardiol 1994, 24:1692-1699.
25. Greenberg RM, Degeratu FT: Use of atrial and ventricular electrograms from a dual chamber implantable cardioverter defibrillator to elucidate complex dysrhythmia. PACE 1998, 21:2002-2004.
26. Schaumann A: Managing atrial tachyarrhythmias in patients with impantable cardioverter defibrillators. Am J Cardiol 1999, 83:214D-217D. This paper gives an overview on management of AF in ICD patients
27. Schaumann A, von zur Mühlen F, Gonska BD, Kreuzer H: Enhanced detection criteria in implantable cardioverterdefibrillators to avoid inappropriate therapy. Am J Cardiol 1996, 78(suppl 5A):42-50.
28. Weber M, Böcker D, Bänsch D, et al. : Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1999, 10:145-153.
29. Weber M, Borggrefe M, Breithardt G, Block M: Inappropriate ICD therapies-incidence, causes and prevention by programming stability and onset criteria. G Ital Cardiol 1998, 28:242-245.
30. Korte T, Jung W, Wolpert C, et al. : A new classification algorithm for discrimination of ventricular from supraventricular tachycardia in a dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 1998, 9:70-73.
31. Jung J, Strauss D, Sinnwell T, et al. : Assessment of intersignal variability for discrimination of atrial flutter. PACE 1998, 21:2426-2430.
32. Jung J, Hohenberg G, Strauss D, et al. : Discrimination of sinus rhythm, atrial flutter and atrial fibrillation using bipolar endocardial leads. J Cardiovasc Electrophysiol 1998, 9:689-695.
33. Fan K, Lee K, Lau CP: Dual chamber implantable cardioverter defibrillator-benefits and limitations. J Intervent Cardiac Electrophysiol 1999, 3:239-245.
34. Tanaka S: An overview of the fifth-generation impantable cardioverter defibrillator. Ann Thorac Cardiovasc Surg 1998, 4:303-311.
35. Jung W, Lüderitz B: Implantation of an arrhythmia management system for patients with ventricular and supraventricular arrhythmias. Lancet 1997, 349:853-854.
36. Jung W, Wolpert C, Esmailzadeh B, et al. : Clinical experience with implantable atrial and combined atrioventricular defibrillators. J Interv Card Electrophysiol 2000, 4(suppl 1):185-195.
37. Wolpert C, Jung W, Scholl C, et al. : Electrical proarrhythmia: Induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator. J Cardiovasc Electrophysiol 1998, 9:859-863.
38. Brecker SJD, Xiao HB, Sparrow J, Gibson DG: Effects of dualchamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992, 340:1308-1312.
39. LeFranc P, Klug D, Lacroix D, et al. : Triple chamber pacemaker for end-stage heart failure in a patient with a previously implanted automatic defibrillator. PACE 1998, 21:1672-1675.
40. Stellbrink C, Auricchio A, Diem B, et al. : Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia. Am J Cardiol 1999, 83:143D-150D.
41. Pfeiffer D, Meisel E, Tebbenjohanns J, et al. : Effect of lead position and shock vector on human defibrillation using a transvenous left coronary vein lead and single biphasic waveform. PACE 2000, 22:1338.
42. Gadler F, Linde C, Daubert C, et al. : Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing in cardiomyopathy. Eur Heart J 1999, 20:1044-1050.
43. Jeanrenaud X, Goy JJ, Kappenberger L: Effects of dual chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992, 339:1318-1323.
44. Borggrefe M, Breithardt G: Is the implantable defibrillator indicated in patients with hypertrophic cardiomyopathy and aborted sudden death? J Am Coll Cardiol 1998, 31:1086-1088.
45. Kappenberger L, Linde C, Daubert C, et al. : and the PIC Study Group: Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 1997, 8:1249-1256.
46. Neuberger H-R, Mewis C, Dörnberger V, et al. : Implantation of a dual chamber pacemaker defibrillator in a patient with hypertrophic obstructive cardiomyopathy. Z Kardiol 1999, 88:521-525.
47. Delfaut P, Saksena S: Electrode assessment in selecting patients for multisite atrial pacing. J Interv Card Electrophysiol 2000, 4(suppl 1):81-85.
48. Grimm W, Flores BF, Marchlinski FE: Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. PACE 1992, 15:1667-1673.
49. Rosenqvist M, Beyer T, Block M, et al. : Adverse events in patients with implantable cardioverter-defibrillator: a prospective study. Circulation 1998, 98:663-670.
50. Neuzner J, Pitschner HF, Schlepper M: Programmable VT detection enhancement in implantable cardioverter defibrillator therapy. PACE 1995, 18:539-547.
51. Brugada J, Mont L, Figueiredo M, et al. : Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol 1998, 9:261-268.
52. Barold H, Newby KH, Tomassoni G, et al. : Prospective evaluation of new and old criteria to discriminate between supraventricular and ventricular tachycardia in implantable defibrillators. PACE 1998, 21:1347-1355.
53. Klingenheben T, Sticherling C, Skupin M, Hohnloser SH: Intracardiac QRS electrogram width-An arrhythmia detection feature for implantable cardioverter defibrillators: Exercise induced variation as a base for device programming. PACE 1998, 21:1609-1617.
54. Lavergne T, Daubert J-C, Chauvin M, et al. : Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997, 20:182-188.
55. Nair M, Saoudi N, Kroiss D, Letac B: Automatic arrhythmia identification using analysis of the atrioventricular association. Application to a new generation of implantable defibrillators. Circulation 1997, 95:967-973.
56. Kühlkamp V, Dörnberger V, Mewis C, et al. : Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999, 10:905-915.
57. Dorian P, Newman D: A randomized clinical trial of a standardized protocol for the prevention of inappropriate therapy using a dual chamber implantable cardioverter defibrillator [abstract. Circulation 1999, 100(suppl 1):I-786.
58. Glotzer TV, Radoslovich GA, Neglia J, Zimmerman JM: Variability of atrial sensing during exercise in a patient with a dual chamber ICD caused inappropriate ICD discharges. PACE 1999, 22:1838-1841.
59. Osswald S, Cron TA, Sterns L, et al. : New ICD-technologies: First clinical experience with dual-chamber sensing for differentiation of supraventricular tachyarrhythmias. PACE 1998, 21:292-295.
60. Grimm W, Menz V, Hoffmann J, Maisch B: Failure of third-generation implantable cardioverter defibrillators to abort shock for therapy for nonsustained ventricular tachycardia due to shortcomings of the VF confirmation algorithm. PACE 1998, 21:722-727.
61. Osswald S, Cron TA, Sterns L, et al. : New ICD-technologies: First clinical experience with dual-chamber sensing for differentiation of supraventricular tachyarrhythmias. PACE 1998, 21:292-295.
62. Niehaus M, Korte T, Schuchert A, et al. : Experiences with a new fractally coated single pass single lead electrode for dual chamber ICD systems in 30 patients [abstract 1119-1197]. J Am Coll Cardiol 2000, 35(suppl A):127.